Retrace offers a network that allows real-time connectivity between payers, providers and patients to enable instant payments based on quality measures.
Intel- and SoftBank-Backed Retrace Launches AI-Based Dental Management Network

Retrace offers a network that allows real-time connectivity between payers, providers and patients to enable instant payments based on quality measures.
Prospective, multinational, randomized, controlled trial designed to support FDA clearance.
Dayspring Lite is a prescription-only treatment for people who need to add basic active compression to their lymphoedema regimen.
“One of the things that we did find was that the durability was pretty good. Up to 3 years, there was still good relief of symptoms.”
This enables commercialization of this novel imaging system for intraoperative histology in the European market.
Showing patients retrospective data has been proven to increase compliance and reduce the need for complex scoliosis surgeries.
Clinical Trials of Madorra Therapy System Show Promising Results for Treatment of Vulvovaginal Atrophy
CMS issues new HCPCS codes for Dayspring, a novel wearable active compression treatment for lymphedema and venous diseases.
Encellin builds implantable “cell pouches” to treat chronic diseases.
The Phoenix is an earbud that addresses the underlying autonomic imbalance of PTSD by delivering transcutaneous auricular vagal nerve stimulation.